MyFinsight
Home
Blog
About
Proceeds from at the
market offering
$1,989K
Proceeds from exercise of
pre-funded warrants
$5K
Net cash provided by
financing activities
$1,829K
Canceled cashflow
$165K
Net decrease in cash
and restricted cash
-$2,560K
Canceled cashflow
$1,829K
Depreciation and
amortization expense
$438K
Stock-based compensation
$157K
Accounts payable
$74K
Accounts receivable
-$15K
Change in fair value of
other liabilities and...
$1K
Payment of financing
costs
$118K
Repayment of financing
lease obligations
$47K
Net cash used in
operating activities
-$4,353K
Canceled cashflow
$685K
Net cash used in
investing activities
-$33K
Effect of exchange rate
changes on cash
-$3K
Net loss
-$4,160K
Operating lease right of
use liability
-$342K
Accrued expenses and
other current...
-$275K
Prepaid expenses and
other current assets
$261K
Purchases of machinery and
equipment
$33K
Back
Back
Cash Flow
Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc. (CLDI)
source: myfinsight.com